What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson’s disease? A preliminary pharmacoepidemiologic study
Table 1
Utilization of psychotropic drugs by class among 935 patients with Parkinson’s disease initiating pramipexole/ropinirole therapy.
Please note that the total number of patients for each drug category is sometimes lower than the sum of all individuals listed for each treatment, since some patients were prescribed more than a single drug in each category.